摘要:
The invention relates to phosphate compounds obtained according to a method comprising reaction of a source of insoluble phosphate with an organic source, principally of vegetable origin, optionally in the presence of a mineral acid or an organic acid, said organic source having at least 10% of complexing functional groups.The compounds of the invention are useful for preparing fertilizer.
摘要:
Novel metal complexes useful in the area of agriculture, notably as agents for treating metal deficiency. The novel metal complexes comprise at least one metal selected from the metal trace elements essential for the development of plants, at least one first ligand selected from the lignosulfonates, and derivatives thereof, and at least one second ligand selected from the multidentate organic ligands.
摘要:
The subject matter of the present invention is a composition for inhibiting urease and nitrification, which may be in liquid or solid form and which comprises at least one compound for inhibiting urease, of phosphoramide type, combined with an essential oil of Allium preferably originating from Allium sativum. This composition may be used in combination with a urea-based fertilizer for the manufacture of fertilizing compositions.
摘要:
An injection method for injecting a substance into eggs, and an injection head for implementing said method. The method generally includes piercing the shell and at least the shell membrane of an egg by moving a needle, and then injecting the treatment substance via said needle, said piercing step comprising a first movement of the needle to pierce the shell with a first penetration force and then a second movement of the needle to pierce at least the shell membrane with a second penetration force lower than the first penetration force.
摘要:
The present invention relates to novel metal complexes comprising: at least one metal selected from the metal trace elements essential for the development of plants; at least one first ligand selected from the lignosulfonates, and derivatives thereof; at least one second ligand selected from the multidentate organic ligands. These complexes are useful in the area of agriculture, notably as agents for treating metal deficiency.
摘要:
The present invention relates to the use of at least one compound of formula (I) or (II), in which R1 is H and n is an integer from 2 to 10, for the preparation of a medicament for treating diseases chosen from the group comprising tumour, cancer, viral disease, bacterial disease, fungal disease, disease of the immune system, auto-immune disease or disease linked to a deficiency in immunostimulation, in human beings and warm-blooded animals. The invention also relates to new products having a mannose or mannitol termination as well as a method for preparing them.
摘要:
Chemotherapeutic antineoplastic method comprising administration of an effective amount of an antineoplastic agent in conjunction with an effective amount of a β-1,3 glucan.
摘要:
The invention concerns the use of a sulphated or phosphated polysaccharide for preparing a drug for treating herpes virus mediated diseases, more particularly mediated by alpha-herpes viruses, and in particular by HSV-1 and HSV-2, as well as by strains of those viruses which are resistant to known antiviral agents. The polysaccharide is preferably sulphated laminarin PS3.
摘要:
The invention relates to the use of an aqueous ionic solution for rinsing contact lenses, particularly contact lenses made of hydrophilic materials. Said aqueous ionic solution is produced from sea water, has an ionic composition that is of the same quality as that of sea water, and the quality of which is such that said aqueous ionic solution has a pH of 4 to 9, preferably 7 to 8, and an osmolality of 150 to 700 mOsm/kg, preferably 250 to 350 mOsm/kg.
摘要:
The present invention relates to compositions and methods for treating humans and warm-blood animals suffering from cancer. More particularly, a therapeutical treatment in which a monoclonal antibody is administered with either β-(1,3)-glucan like laminarin or a oligo-β-(1,3)-glucan and a pharmaceutically acceptable carrier, to patients suffering from cancer are described.